NCT06764628View on ClinicalTrials.gov

A Study of SHR-4375 in Subjects With Solid Tumors

PHASE1/PHASE2RecruitingINTERVENTIONAL

Enrollment

208

Participants

Timeline

Start Date

January 9, 2025

Primary Completion Date

May 31, 2027

Study Completion Date

May 31, 2027

Conditions

Solid Tumors

Interventions

DRUG

SHR-4375

SHR-4375 injection

Trial Locations (1)

200032

RECRUITING

Fudan University Shanghai Cancer Center, Shanghai

All Listed Sponsors

lead

Suzhou Suncadia Biopharmaceuticals Co., Ltd.

INDUSTRY